vs
BEASLEY BROADCAST GROUP INC（BBGI）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
BEASLEY BROADCAST GROUP INC的季度营收约是REGENXBIO Inc.的1.7倍（$53.1M vs $30.3M），REGENXBIO Inc.净利率更高（-221.3% vs -358.4%，领先137.1%），REGENXBIO Inc.同比增速更快（43.0% vs -21.2%），BEASLEY BROADCAST GROUP INC自由现金流更多（$-4.4M vs $-52.8M），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs -1.2%）
比斯利广播集团总部位于美国佛罗里达州那不勒斯，是美国本土一家广播电台运营企业。截至2025年9月，该公司以比斯利媒体集团品牌旗下共拥有54家广播电台，是美国广播传媒行业的知名运营商之一。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
BBGI vs RGNX — 直观对比
营收规模更大
BBGI
是对方的1.7倍
$30.3M
营收增速更快
RGNX
高出64.2%
-21.2%
净利率更高
RGNX
高出137.1%
-358.4%
自由现金流更多
BBGI
多$48.4M
$-52.8M
两年增速更快
RGNX
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.1M | $30.3M |
| 净利润 | $-190.1M | $-67.1M |
| 毛利率 | — | — |
| 营业利润率 | -433.6% | -190.0% |
| 净利率 | -358.4% | -221.3% |
| 营收同比 | -21.2% | 43.0% |
| 净利润同比 | -9136.7% | -31.2% |
| 每股收益（稀释后） | $-105.71 | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBGIRGNX
| Q4 25 | $53.1M | $30.3M | ||
| Q3 25 | $51.0M | $29.7M | ||
| Q2 25 | $53.0M | $21.4M | ||
| Q1 25 | $48.9M | $89.0M | ||
| Q4 24 | $67.3M | $21.2M | ||
| Q3 24 | $58.2M | $24.2M | ||
| Q2 24 | $60.4M | $22.3M | ||
| Q1 24 | $54.4M | $15.6M |
净利润BBGIRGNX
| Q4 25 | $-190.1M | $-67.1M | ||
| Q3 25 | $-3.6M | $-61.9M | ||
| Q2 25 | $-154.2K | $-70.9M | ||
| Q1 25 | $-2.7M | $6.1M | ||
| Q4 24 | $-2.1M | $-51.2M | ||
| Q3 24 | $-3.6M | $-59.6M | ||
| Q2 24 | $-276.0K | $-53.0M | ||
| Q1 24 | $8.0K | $-63.3M |
毛利率BBGIRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 70.2% | ||
| Q3 24 | — | 48.8% | ||
| Q2 24 | — | 52.5% | ||
| Q1 24 | — | 72.6% |
营业利润率BBGIRGNX
| Q4 25 | -433.6% | -190.0% | ||
| Q3 25 | -1.1% | -176.3% | ||
| Q2 25 | 5.5% | -296.3% | ||
| Q1 25 | -4.1% | 13.6% | ||
| Q4 24 | 11.3% | -242.1% | ||
| Q3 24 | 2.1% | -256.6% | ||
| Q2 24 | 8.9% | -251.3% | ||
| Q1 24 | -2.0% | -408.8% |
净利率BBGIRGNX
| Q4 25 | -358.4% | -221.3% | ||
| Q3 25 | -7.0% | -208.3% | ||
| Q2 25 | -0.3% | -331.8% | ||
| Q1 25 | -5.5% | 6.8% | ||
| Q4 24 | -3.1% | -241.3% | ||
| Q3 24 | -6.1% | -246.3% | ||
| Q2 24 | -0.5% | -237.7% | ||
| Q1 24 | 0.0% | -405.4% |
每股收益（稀释后）BBGIRGNX
| Q4 25 | $-105.71 | $-1.30 | ||
| Q3 25 | $-1.97 | $-1.20 | ||
| Q2 25 | $-0.09 | $-1.38 | ||
| Q1 25 | $-1.50 | $0.12 | ||
| Q4 24 | $-1.23 | $-0.99 | ||
| Q3 24 | $-2.33 | $-1.17 | ||
| Q2 24 | $-0.18 | $-1.05 | ||
| Q1 24 | $0.01 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $230.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-49.3M | $102.7M |
| 总资产 | $299.3M | $453.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BBGIRGNX
| Q4 25 | $9.9M | $230.1M | ||
| Q3 25 | $14.3M | $274.2M | ||
| Q2 25 | $13.7M | $323.3M | ||
| Q1 25 | $12.2M | $267.9M | ||
| Q4 24 | $13.8M | $234.7M | ||
| Q3 24 | $27.8M | $255.5M | ||
| Q2 24 | $33.3M | $290.4M | ||
| Q1 24 | $27.8M | $338.7M |
总债务BBGIRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $247.1M | — | ||
| Q3 24 | $265.2M | — | ||
| Q2 24 | $264.9M | — | ||
| Q1 24 | $264.5M | — |
股东权益BBGIRGNX
| Q4 25 | $-49.3M | $102.7M | ||
| Q3 25 | $141.0M | $161.5M | ||
| Q2 25 | $144.5M | $213.7M | ||
| Q1 25 | $144.6M | $274.2M | ||
| Q4 24 | $147.2M | $259.7M | ||
| Q3 24 | $145.8M | $301.4M | ||
| Q2 24 | $149.1M | $348.3M | ||
| Q1 24 | $149.1M | $390.7M |
总资产BBGIRGNX
| Q4 25 | $299.3M | $453.0M | ||
| Q3 25 | $534.6M | $525.2M | ||
| Q2 25 | $548.0M | $581.0M | ||
| Q1 25 | $539.3M | $490.9M | ||
| Q4 24 | $549.2M | $466.0M | ||
| Q3 24 | $571.5M | $519.1M | ||
| Q2 24 | $573.2M | $569.4M | ||
| Q1 24 | $566.3M | $629.2M |
负债/权益比BBGIRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.68× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | 1.78× | — | ||
| Q1 24 | 1.77× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | $-4.4M | $-52.8M |
| 自由现金流率自由现金流/营收 | -8.3% | -174.0% |
| 资本支出强度资本支出/营收 | 2.3% | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.3M | $-126.4M |
8季度趋势，按日历期对齐
经营现金流BBGIRGNX
| Q4 25 | $-3.2M | $-52.3M | ||
| Q3 25 | $-4.9M | $-56.0M | ||
| Q2 25 | $3.1M | $-49.3M | ||
| Q1 25 | $-3.5M | $33.6M | ||
| Q4 24 | $-1.5M | $-31.6M | ||
| Q3 24 | $-4.8M | $-40.5M | ||
| Q2 24 | $6.6M | $-45.5M | ||
| Q1 24 | $-4.0M | $-55.5M |
自由现金流BBGIRGNX
| Q4 25 | $-4.4M | $-52.8M | ||
| Q3 25 | $-7.1M | $-56.5M | ||
| Q2 25 | $2.5M | $-49.7M | ||
| Q1 25 | $-4.3M | $32.6M | ||
| Q4 24 | $-1.9M | $-32.7M | ||
| Q3 24 | $-5.4M | $-40.9M | ||
| Q2 24 | $5.6M | $-46.0M | ||
| Q1 24 | $-5.0M | $-56.0M |
自由现金流率BBGIRGNX
| Q4 25 | -8.3% | -174.0% | ||
| Q3 25 | -14.0% | -189.9% | ||
| Q2 25 | 4.7% | -232.8% | ||
| Q1 25 | -8.7% | 36.6% | ||
| Q4 24 | -2.8% | -154.2% | ||
| Q3 24 | -9.3% | -168.9% | ||
| Q2 24 | 9.2% | -206.2% | ||
| Q1 24 | -9.2% | -358.5% |
资本支出强度BBGIRGNX
| Q4 25 | 2.3% | 1.7% | ||
| Q3 25 | 4.4% | 1.7% | ||
| Q2 25 | 1.1% | 1.8% | ||
| Q1 25 | 1.6% | 1.2% | ||
| Q4 24 | 0.6% | 5.1% | ||
| Q3 24 | 1.1% | 1.3% | ||
| Q2 24 | 1.7% | 2.1% | ||
| Q1 24 | 1.7% | 3.6% |
现金转化率BBGIRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -506.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBGI
| Audio Advertising | $40.5M | 76% |
| Digital Advertising | $12.6M | 24% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
